Published in Biokhimiia on October 01, 1991
The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol (2000) 2.69
Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem (1997) 2.31
Role of Hsp70 in regulation of stress-kinase JNK: implications in apoptosis and aging. FEBS Lett (1998) 1.57
Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol Cell Biol (2000) 1.42
The function of HSP72 in suppression of c-Jun N-terminal kinase activation can be dissociated from its role in prevention of protein damage. J Biol Chem (1999) 1.05
Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stewss-induced inhibition of JNK dephosphorylation. J Biol Chem (2000) 1.02
DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol (2006) 0.94
[The frequency of antibodies against delta virus in patients with HBs positive hepatitis]. Vopr Virusol (1997) 0.90
Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Dokl Biochem Biophys (2007) 0.89
Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) (2012) 0.88
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) (2006) 0.84
Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response. Vaccine (2008) 0.83
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.83
Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes (1990) 0.82
[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81
[Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics]. Mol Biol (Mosk) (2009) 0.81
Atomic force microscopy study of peptides homologous to beta-domain of alpha-lactalbumins. Protein Pept Lett (2007) 0.81
[Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med (1996) 0.81
DNA sequencing with thermostable Tet DNA polymerase from Thermus thermophilus. Nucleic Acids Res (1989) 0.80
Recombinant influenza vaccines. Acta Naturae (2012) 0.80
The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79
[Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin]. Mol Biol (Mosk) (1995) 0.79
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78
[Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses]. Vopr Virusol (2014) 0.78
[Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection]. Biull Eksp Biol Med (1992) 0.78
[Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter (2010) 0.77
[Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter (2010) 0.77
[In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus]. Vopr Virusol (2011) 0.77
[Effect of different water-soluble forms of the fullerene C60 on the metabolic activity and ultra-structure of cells in culture]. Biofizika (2012) 0.77
[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter (2010) 0.77
Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett (1989) 0.77
[Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77
Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein. Acta Naturae (2010) 0.77
[The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk (2004) 0.76
[Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.76
Insulin fibrillogenesis in vitro. Dokl Biochem Biophys (2008) 0.76
[Universal influenza vaccines: developments, prospects for use]. Vopr Virusol (2012) 0.76
[Development of the anti-influenza H5N1 vaccines worldwide and in Russia]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.76
[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76
[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter (2011) 0.75
[Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models]. Eksp Klin Farmakol (2007) 0.75
[Characterization of cold-adapted influenza strain A/HongKong/1/68/162/35 as a potential donor of attenuation and high reproduction]. Vopr Virusol (2013) 0.75
[Clinical trial of new inactivated influenza vaccine "Grifor"]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.75
[Pandemic influenza 2009 in Russia. Characteristics of the isolation and biological properties of viruses]. Vopr Virusol (2011) 0.75
[Inhibiting effect of no-spa on paragrippe virus reproduction]. Biull Eksp Biol Med (1999) 0.75
[Development of novel drugs against influenza virus based on synthetic and natural compounds]. Vopr Virusol (2013) 0.75
[The role of influenza virus hemagglutinin in blood anticoagulation processes]. Vopr Virusol (1997) 0.75
[Cell therapy in treatment of trophic ulcers of lower extremities]. Vestn Khir Im I I Grek (2006) 0.75
[Comparative study of the differential susceptibility of different cell lines to pandemic H1N1v influenza viruses and avian influenza, swine influenza, and human influenza viruses]. Vopr Virusol (2012) 0.75
[Current approaches to the treatment of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[A new antiviral drug Triazavirin: results of phase II clinical trial]. Vopr Virusol (2013) 0.75
[An analysis of the potential areas of recombination in the hemagglutinin genes of animal influenza viruses in relation to their adaptation to a new host--man]. Vopr Virusol (1994) 0.75
[ Influenza virus proteins modulate hemostasis in vitro and in vivo ]. Izv Akad Nauk Ser Biol (2004) 0.75
[Effect of antiviral drugs with various mechanisms of action on morphogenesis of infection caused by extremely pathogenic influenza virus strains in animals]. Eksp Klin Farmakol (2011) 0.75
[Immunosuppression at pregnancy and flu]. Vopr Virusol (2013) 0.75
[Structure and antiviral activity of adamantane-containing polymer preparation]. Vopr Virusol (2003) 0.75
[Deitiforine, an antiinfluenza chemotherapeutic]. Antibiot Khimioter (2013) 0.75
[Effect of Ingavirin on the ultrastructure of the morphogenesis of adenovirus infection in vivo]. Vopr Virusol (2012) 0.75
[Evaluation of metabolic parameters in vitro as a model for testing the cytotoxicity of antiviral drugs]. Eksp Klin Farmakol (2006) 0.75
[Usage of polymerase chain reaction in complex diagnosis of hepatitis B]. Vopr Virusol (2000) 0.75
[Antiviral activity of Ingavirin on an animal model for experimental disseminated adenovirus infection]. Vopr Virusol (2012) 0.75
[Molecular bases of prion diseases]. Vestn Ross Akad Med Nauk (1998) 0.75
[The use of apoptosis inducers in the therapy of experimental influenza infection and preventing of chronic post-influenza lung damage]. Tsitologiia (2014) 0.75
[The molecular mechanism of the action of antiviral preparations in the adamantane series]. Vestn Ross Akad Med Nauk (1993) 0.75
[Isolation and cloning of gene for hepatitis delta antigen. The use of recombinant antigen for serodiagnosis of delta infection]. Mol Gen Mikrobiol Virusol (1998) 0.75
[Long-term carriers of genomic structures of the influenza virus in the blood leukocytes of children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk (1994) 0.75
[Pathogenesis of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[Epizootics of "avian" influenza as the manifestation of pandemic]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.75
[Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR]. Ter Arkh (2015) 0.75
[Influenza: current status and epidemiologic situation]. Vestn Ross Akad Med Nauk (1994) 0.75
[Prognostic value of human papilloma virus DNA test in patients surgically treated for squamous cell cervical cancer]. Vopr Onkol (2012) 0.75
[Quantitative competitive PCR--diagnostic method for monitoring cytomegalovirus infection and antiviral therapy]. Mol Biol (Mosk) (2000) 0.75
[Polymorphism of current human influenza A and B virus population]. Vestn Ross Akad Med Nauk (1994) 0.75
[Transformation of eucaryotic cells with complexes of plasmid DNA and polycations]. Dokl Akad Nauk (1999) 0.75
[Antiviral activity of fullerene (60)C complexed with poly(N-vinylpyrrolidone)]. Dokl Akad Nauk (1998) 0.75
[Comparison of the influenza epidemics in Russia caused by the pandemic virus A(H1N1)pdm09 within the period from 2009 to 2013]. Vopr Virusol (2015) 0.75
[Technological approaches to development of whole-virion inactivated vaccine from recombinant strain against A/H5N1 influenza in the Republic of Kazakhstan]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[A new method of producing biologically active nanocomplexes by non-covalent conjugation of proteins with viral particles]. Bioorg Khim (2011) 0.75
[Molecular-biological properties of the rubella virus strains isolated in St. Petersburg]. Mol Biol (Mosk) (2012) 0.75
[Effect of polymer carrier origin and physical state on fullerene C60 phototoxicity in vitro]. Eksp Klin Farmakol (2011) 0.75
[Ingavirin treatment of experimental parainfluenza pneumonia in Syrian hamsters]. Vopr Virusol (2012) 0.75
[Intranasal co-administration of recombinant streptococcus group B polypeptides and influenza deltaNS1 vaccine]. Vopr Virusol (2013) 0.75
[The effect of influenza virus hemagglutinin on erythrocytes and thrombocytes]. Izv Akad Nauk Ser Biol (1999) 0.75
[The International Scientific Conference on the Optimization of Influenza Control]. Vopr Virusol (1994) 0.75
[Preclinical studies of live intranasal H5N1 influenza vaccine with the deleted HS1 gene]. Vopr Virusol (2012) 0.75
[H1N1V influenza epidemic of 2009 in Russia]. Vestn Ross Akad Med Nauk (2011) 0.75
[Genetic diversity and molecular evolution of the influenza A viruses in Russia during 2006-2012]. Vopr Virusol (2013) 0.75
[Anti-HIV activity of complex isoborneol ethers]. Dokl Akad Nauk (1992) 0.75
[Effect of fullerene C60-polyvinilpyrrolidone complexes on influenza virus reproduction]. Vopr Virusol (2001) 0.75
No-Spa and Remantadin are the novel complex preparations that inhibit effectively reproduction of the avian influenza viruses. Dokl Biol Sci (2007) 0.75
[Features of interepidemic influenza A and B viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[International symposium on military-civilian cooperation in surveillance and control of influenza]. Vopr Virusol (2004) 0.75
[Studying the effect of antioxidants and/or antihypoxants on cell cultures under conditions of cytotoxic action of rimantadine]. Eksp Klin Farmakol (2007) 0.75
[Human papilloma virus and lymphatic metastasis in squamous cell carcinoma of the cervix]. Vopr Onkol (2011) 0.75
[Determination of nucleotide sequences of Russian isolates of delta hepatitis virus]. Mol Gen Mikrobiol Virusol (1997) 0.75
Study of protein components of natural peptide regulators. Bull Exp Biol Med (2003) 0.75
[Prevention of tuberculosis: current approaches to development of vaccines]. Vestn Ross Akad Med Nauk (2012) 0.75
[Bird flu as a global biocatastrophe (editorial)]. Ter Arkh (2006) 0.75
[Use of liposomes for vaccines design]. Vopr Virusol (2001) 0.75
[The etiological structure of the morbidity from influenza and other ARDs on the territory of Russia in the season of 1997-1998]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75